#9,896 by institutional money · Stock
Aspire Biopharma Holdings, Inc. (ASBP)
Institutional ownership from Q3 2026 Form 13F filings
$7.65
−3.04% today
Market closed. Prices as of Nov 20, 7:41 AM ET
- 13F holders
- 9 (−2)
- Held by 13F filers, live
- $870K
- Shares held
- 113,766
- Share of stock outstanding
- 8.1%
- Net buying in Q3 2026
- +$511K
- New positions / sold out
- 1 / 3
Largest holders
9 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Jane Street Group, LLC | 44,632 | $341K | <0.1% | Added +201% |
| FNY Investment Advisers, LLC | 27,759 | $212K | <0.1% | New |
| Vanguard Capital Management LLC | 18,825 | $144K | <0.1% | Added +81% |
| Geode Capital Management, LLC | 16,025 | $123K | <0.1% | Added +53% |
| Vanguard Fiduciary Trust Co | 4,438 | $34K | <0.1% | Reduced −56% |
| Tower Research Capital LLC (TRC) | 1,243 | $10K | <0.1% | Added +339% |
| Crewe Advisors LLC | 677 | $5K | <0.1% | Unchanged |
| Toronto Dominion Bank | 166 | $1K | <0.1% | Unchanged |
| UBS Group AG | 1 | $8 | <0.1% | Unchanged |